Alteogen, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer (NCT05232175) | Alteogen, Inc. | 2022-01-18 |
| Clinical Study of ALT-L9 to Determine Safety, Efficacy and Pharmacokinetics in Neovascular AMD (NCT04058535) | Alteogen, Inc. | 2020-02-05 |
| Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients (NCT03281824) | Alteogen, Inc. | 2018-01-11 |
| A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects (NCT03242239) | Alteogen, Inc. | 2016-02-09 |
Track Alteogen, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.